Clinical Trial Update: A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the effects of vildagliptin on gastric emptying in adults with type 2 diabetes, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED